Sign up for access to exclusive content, events, materials and updates from OWL.
Rarely will you find a value as great as an OWL membership! By becoming a member you establish yourself as committed to "Advancing Diversity in Leadership" and in standing as a leader for today's world. You'll also be affiliated with the best and brightest in Ophthalmology. Take a look here at some of our Champion members!
LEARN MOREA Conversation with Eris Jordan, OD, Vice President of Clinical and Medical Affairs at Aurion Biotech and OWL Champion Member…
It’s time to honor your peers who are advancing diversity in leadership.OWL is pleased to accept nominations for the 2022…
On June 21, 2022, OWL and Alcon collaborated to host our second annual virtual program “Eyes on Inclusion: Transitioning to…
Developing leaders is OWL's mission and our specialty! Get terrific experience and benefit from the best-of-the-best networking in Ophthalmology when you get involved in OWL:
OWL is a 501(c)3 organization, meaning any financial contribution is 100% tax-deductible. OWL focuses the investment of members’ dues on programs and events that will benefit members (our admin costs are low compared to other nonprofits).
Your company can align with OWL's mission by having a presence at our events and benefit from exposure on our social mediachannels and in our member communications. Organizations and companies that want to be involved at the highest level can enroll their associates as virtual members, receive educational programs and get sponsorship exposure by becoming an OWL Partner.
LEARN MOREThe OWL Awards are given annually at OWL's Signature Event during AAO. The finalists are distinguished and respected - always an impressive group!
Nominations for the OWL Awards open in the Summer. A Nominations Committee selects the finalists and then OWL members cast their votes in the Fall.
Contact Us for information on nominating a colleague as a ‘Rising Star’, ‘Catalyst’ or ‘Visionary’ in Ophthalmology.
LEARN MORE
Dr. Sharon Klier is VP and Medical Director, Ophthalmology at UNITY Biotechnology. In her role, Dr. Klier leads the Ophthalmology franchise at the company, overseeing global development programs from early clinical phase to registration studies, directly responsible for conceiving and implementing clinical strategy of the development programs, as well as design and execution of international clinical studies, oversight, interpretation and reporting of clinical trials data.
Dr. Klier received her MD from the Technion, Israel Institute of Technology, School of Medicine, and her MPH in Public Health Policy and Management from UCLA where she also received her Bachelor of Science in Physiology.
SVP, Sales & Marketing,
CBCC Global Research
Sanjeev has 20 years of commercial experience in pharma/med device, medical practice, managed care, biotech, and technology. He is part of the leadership team at CBCC Global Research, a clinical research organization focused on supporting drug/device/diagnostic innovation in ophthalmology, oncology, neuro/psych and medical device development globally. Sanjeev has been a part of the growth or turnaround of various size companies from as large as Pfizer and Biogen to mid-size organizations such as VisionCare Ophthalmic Technologies (now Samsara), Ora, ISTA (now part of Bausch + Lomb), and Avanir Pharmaceuticals (now part of Otsuka). On the medical practice side, Sanjeev was VP of Corporate Development for a multi-site eyecare practice and was responsible for acquisition or divestiture of practices and entities within the practice network. On the technology side, he has worked with TrialCard (managing patient drug benefits), and for Sun Microsystems as well as starting and advising multiple technology start-ups. Sanjeev has served in senior commercial roles in Sales Management, Analytics & Operations management, and Marketing management in healthcare specialties ranging from Oncology, Ophthalmology, Women’s health, GI, Dermatology, and Neuroscience.
More OWL Champions